GSK Investigational Site

Argenteuil 95107

0 studies enrolling now · 3 studies all time

What they study most

Asthma, Sepsis, Severe Acute Respiratory Syndrome

Studies at this site

• A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma — Completed
• Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease — Completed
• GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults — Completed